V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159692 | 20061379 | 1.7 | 87 | Palliative (P) | 2018-12-05 | 2018-12-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100049635 |
| 20159693 | 20061380 | 1.73 | 106.6 | Curative (C) | 2017-07-09 | 2017-07-24 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101230799 |
| 20159694 | 20061381 | 1.68 | 68.5 | Palliative (P) | 2016-11-30 | 2016-12-11 | ECX | N | N | ECX | 101612081 |
| 20159695 | 20061382 | 1.57 | 60.4 | Neo-adjuvant (N) | null | 2017-06-19 | ECX | N | N | ECX | 101634165 |
| 20159696 | 20061383 | 1.69 | 74 | Neo-adjuvant (N) | 2019-12-04 | 2019-12-05 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100743107 |
| 20159697 | 20061384 | 1.74 | 90 | Adjuvant (A) | 2017-04-03 | 2017-04-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100610393 |
| 20159698 | 20061385 | 1.7 | 71 | Palliative (P) | 2019-10-05 | 2019-10-29 | ECX | 02 | N | ECX | 100555061 |
| 20159700 | 20061386 | 1.83 | 56.85 | Neo-adjuvant (N) | 2017-11-06 | 2017-11-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100158824 |
| 20159701 | 20061387 | 1.7 | 69.4 | Palliative (P) | 2016-12-06 | 2016-12-06 | ECX | 02 | N | ECX | 100882962 |
| 20159702 | 20061388 | 1.58 | 83.5 | Neo-adjuvant (N) | 2017-03-13 | 2017-03-20 | ECX | 02 | null | ECX | 100838496 |
| 20159703 | 20061389 | 1.6 | 71 | Neo-adjuvant (N) | 2018-12-25 | 2018-12-25 | ECX | N | N | ECX | 100098314 |
| 20159704 | 20061390 | 1.61 | 91 | Neo-adjuvant (N) | 2016-11-26 | 2016-12-07 | ECX | N | N | ECX | 100981120 |
| 20159705 | 20061391 | 1.62 | 90.9 | Neo-adjuvant (N) | 2019-10-01 | 2019-10-22 | ECX | 02 | N | ECX | 100620732 |
| 20159707 | 20061392 | 1.72 | 76 | Curative (C) | 2017-12-20 | 2017-12-26 | ECX | 2 | N | ECX | 100689855 |
| 20159709 | 20061393 | 1.72 | 72.7 | Adjuvant (A) | 2018-07-18 | 2018-07-29 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101102977 |
| 20159710 | 20061394 | 1.85 | 107.8 | Neo-adjuvant (N) | null | 2017-06-19 | ECX | N | N | ECX | 100608244 |
| 20159713 | 20061395 | 1.75 | 70.4 | Palliative (P) | 2018-01-28 | 2018-01-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101589123 |
| 20159714 | 20061396 | 1.53 | 104 | Adjuvant (A) | 2018-12-05 | 2018-12-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101644154 |
| 20159719 | 20061397 | 1.64 | 64.8 | Palliative (P) | 2016-03-10 | 2016-04-01 | ECX | 02 | N | ECX | 101066724 |
| 20159721 | 20061398 | 1.79 | 65.75 | Neo-adjuvant (N) | 2017-10-01 | 2017-10-01 | ECX | 2 | N | ECX | 101269640 |
| 20159722 | 20061399 | 1.78 | 85.7 | Palliative (P) | 2016-05-27 | 2016-05-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100398849 |
| 20159724 | 20061400 | 1.8 | null | 02 | 2021-07-12 | 2021-08-09 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100699397 |
| 20159727 | 20061401 | 1.55 | 80.5 | Palliative (P) | 2016-11-07 | 2016-11-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100650318 |
| 20159728 | 20061402 | 1.7 | 59 | Adjuvant (A) | 2020-01-29 | 2020-02-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100778151 |
| 20159729 | 20061403 | 1.61 | 43.5 | Palliative (P) | 2019-12-26 | 2020-01-05 | ECX | null | N | ECX | 100551377 |
| 20159730 | 20061404 | 1.59 | 80 | Adjuvant (A) | 2017-04-09 | 2017-05-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100090253 |
| 20159731 | 20061405 | 1.75 | 68.7 | Neo-adjuvant (N) | null | 2018-05-13 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101620043 |
| 20159732 | 20061406 | 1.7 | 88.4 | Adjuvant (A) | 2019-05-12 | 2019-06-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100732769 |
| 20159736 | 20061407 | 1.77 | 64 | Adjuvant (A) | 2017-09-27 | 2017-10-16 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100157744 |
| 20159738 | 20061408 | 1.8 | 61.2 | Palliative (P) | 2016-08-13 | 2016-08-27 | ECX | 02 | N | ECX | 101095311 |
| 20159741 | 20061409 | 1.6 | 63.4 | Palliative (P) | 2018-09-28 | 2018-09-28 | ECX | N | null | ECX | 101699100 |
| 20159743 | 20061410 | null | 67.9 | Adjuvant (A) | 2017-07-02 | 2017-07-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101738232 |
| 20159745 | 20061411 | 1.6 | 86.6 | Palliative (P) | 2017-06-22 | 2017-06-22 | ECX | 02 | N | ECX | 101696955 |
| 20159746 | 20061412 | 1.64 | 97 | Adjuvant (A) | 2019-02-05 | 2019-02-05 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101393924 |
| 20159747 | 20061413 | 1.66 | 79 | Adjuvant (A) | 2016-08-23 | 2016-10-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100632491 |
| 20159749 | 20061414 | 1.97 | 76 | Neo-adjuvant (N) | 2019-08-17 | 2019-09-06 | ECX | N | N | ECX | 100030408 |
| 20159750 | 20061415 | 1.51 | 64.7 | Palliative (P) | 2017-11-24 | 2017-11-24 | ECX | 2 | N | ECX | 101442863 |
| 20159752 | 20061416 | 1.56 | 64 | Neo-adjuvant (N) | 2017-05-20 | 2017-05-28 | ECX | N | N | ECX | 101223995 |
| 20159754 | 20061417 | 1.77 | 65 | Palliative (P) | 2019-12-13 | 2020-01-03 | ECX | 02 | N | ECX | 100431215 |
| 20159757 | 20061418 | 1.63 | 108 | Palliative (P) | 2016-07-13 | 2016-08-14 | ECX | N | N | ECX | 101235347 |
| 20159758 | 20061419 | 1.8 | 98.8 | Palliative (P) | 2017-06-02 | 2017-06-11 | ECX | N | N | ECX | 100446674 |
| 20159759 | 20061420 | 1.55 | 54 | Palliative (P) | 2017-06-27 | 2017-07-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101454566 |
| 20159760 | 20061421 | 1.57 | 76 | Neo-adjuvant (N) | 2017-06-02 | 2017-06-02 | ECX | N | N | ECX | 101054688 |
| 20159761 | 20061422 | 1.6 | 76.8 | Palliative (P) | 2019-07-30 | 2019-08-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100279589 |
| 20159762 | 20061423 | 1.72 | 52 | Adjuvant (A) | null | 2018-01-10 | ECX | N | N | ECX | 100483347 |
| 20159763 | 20061424 | 1.6 | 77.6 | Adjuvant (A) | 2018-08-05 | 2018-08-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101257560 |
| 20159764 | 20061425 | 1.54 | 86.5 | Palliative (P) | 2017-08-22 | 2017-08-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100024090 |
| 20159765 | 20061426 | 1.6 | 52.7 | Palliative (P) | 2018-07-21 | 2018-08-02 | ECX | N | N | ECX | 101140799 |
| 20159770 | 20061427 | null | 72.4 | Palliative (P) | 2019-09-23 | 2019-10-09 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101768347 |
| 20159773 | 20061428 | 1.7 | 83.9 | null | 2018-06-29 | 2018-06-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101712543 |